TP53 and acute myeloid leukemia: After treatment of AML cells with securinine, we observed limited DNA damage (as measured by H2AX phosphorylation) and the activation of DNA damage signaling (as measured by Chk1 phosphorylation and the induction of p53 and p21) (figure 5a).